Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loopYingying Shen, Xuyu Zu|Cell Death and Disease|2022Cited by 36
Therapeutic activity of DCC‐2036, a novel tyrosine kinase inhibitor, against triple‐negative breast cancer patient‐derived xenografts by targeting AXL/METYingying Shen, Xuyu Zu|International Journal of Cancer|2018Cited by 32
Protein arginine N-methyltransferase�2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36Yingying Shen, Renxian Cao|Oncology Reports|2018Cited by 19
Negative feedback loop between ZBTB7A and TGF-β in breast cancerYingying Shen, Xuyu Zu|Oncology Letters|2017Cited by 13
Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cellsYingying Shen, Jingxuan Pan|Oncotarget|2014Cited by 12